Since then, studies have consistently shown reduced CD39 expression on pulmonary vascular ECs from patients with idiopathic PAH compared with healthy controls [22, 56] and interestingly, CD39 expression is reduced in vessels with more severe vessel remodelling [6]. This evidence concerns the gene ENTPD1 and pulmonary arterial hypertension.